Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors (Q30975099)

27 June 2017

Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors (English)

1 reference

27 June 2017

0 references

0 references

4

Renata Pasqualini

1 reference

27 June 2017

5

Wadih Arap

1 reference

27 June 2017

Oliver J Müller

1

1 reference

27 June 2017

Felix Kaul

2

1 reference

27 June 2017

Matthew D Weitzman

3

1 reference

27 June 2017

Jürgen A Kleinschmidt

6

1 reference

27 June 2017

Martin Trepel

7

1 reference

27 June 2017

3 August 2003

1 reference

27 June 2017

1 reference

27 June 2017

21

1 reference

27 June 2017

1040-1046

1 reference

27 June 2017

9

1 reference

Gene therapy: trials and tribulations

27 June 2017

1 reference

7 January 2021

Cancer gene therapy: fringe or cutting edge?

1 reference

7 January 2021

Clinical research. Gene therapy a suspect in leukemia-like disease

1 reference

7 January 2021

1 reference

7 January 2021

In vivo phage display and vascular heterogeneity: implications for targeted medicine

1 reference

7 January 2021

Organ targeting in vivo using phage display peptide libraries

1 reference

7 January 2021

Steps toward mapping the human vasculature by phage display.

1 reference

7 January 2021

Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries

1 reference

7 January 2021

A tumor-homing peptide with a targeting specificity related to lymphatic vessels

1 reference

7 January 2021

Anti-cancer activity of targeted pro-apoptotic peptides

1 reference

7 January 2021

Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13).

1 reference

7 January 2021

Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody

1 reference

7 January 2021

A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo

1 reference

7 January 2021

Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

1 reference

7 January 2021

Conjugate-based targeting of recombinant adeno-associated virus type 2 vectors by using avidin-linked ligands

1 reference

7 January 2021

Molecular adaptors for vascular-targeted adenoviral gene delivery

1 reference

7 January 2021

Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells

1 reference

7 January 2021

Incorporation of tumor-targeting peptides into recombinant adeno-associated virus capsids

1 reference

7 January 2021

AAV vectors: is clinical success on the horizon?

1 reference

7 January 2021

Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions

1 reference

7 January 2021

AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection

1 reference

7 January 2021

Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2.

1 reference

7 January 2021

Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding

1 reference

7 January 2021

Monoclonal antibodies against the adeno-associated virus type 2 (AAV-2) capsid: epitope mapping and identification of capsid domains involved in AAV-2-cell interaction and neutralization of AAV-2 infection

1 reference

7 January 2021

Epitope mapping of human anti-adeno-associated virus type 2 neutralizing antibodies: implications for gene therapy and virus structure

1 reference

7 January 2021

Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2.

1 reference

7 January 2021

Insertional mutagenesis of AAV2 capsid and the production of recombinant virus

1 reference

7 January 2021

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

1 reference

7 January 2021

Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors

1 reference

7 January 2021

The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy.

1 reference

7 January 2021

Role for highly regulated rep gene expression in adeno-associated virus vector production

1 reference

7 January 2021

Cell-type-specific characteristics modulate the transduction efficiency of adeno-associated virus type 2 and restrain infection of endothelial cells

1 reference

7 January 2021

Genes expressed in human tumor endothelium

1 reference

7 January 2021

A striking organization of a large family of human neural cadherin-like cell adhesion genes

1 reference

7 January 2021

Production and purification of recombinant adeno-associated virus

1 reference

7 January 2021

Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2.

1 reference

7 January 2021

A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells

1 reference

7 January 2021

Identifiers

DOI

10.1038/NBT856

1 reference

release_wyf63mqcf5an7hwpjpdmvjmqsi

27 June 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/wyf63mqcf5an7hwpjpdmvjmqsi

24 November 2022

mapped directly with Wikidata item

1 reference